elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q33779847-1C18B952-D329-462A-AB94-31ABA1AC8072
Q33779847-1C18B952-D329-462A-AB94-31ABA1AC8072
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33779847-1C18B952-D329-462A-AB94-31ABA1AC8072
MRI of breast tumor initiating cells using the extra domain-B of fibronectin targeting nanoparticles.
P2860
Q33779847-1C18B952-D329-462A-AB94-31ABA1AC8072
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33779847-1C18B952-D329-462A-AB94-31ABA1AC8072
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
de60bd0cbd5ccd2a1ee4489c5189ef8a452d8d41
P2860
Therapeutic antibodies: successes, limitations and hopes for the future.